The US Neurodegenerative Disease Market growth is driven by the rising prevalence of neurological disorders, advances in drug development, and increasing patient awareness. Growth is particularly influenced by the adoption of gene therapies, monoclonal antibodies, and targeted small-molecule drugs. Development of novel drug formulations and combination therapies is expanding treatment options...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek